GlobalData on MSN
FDA accepts Otsuka’s centanafadine application for ADHD treatment
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...
Health and well-being don't jump to mind when discussing adult ADHD, and neither do poor health, suffering, disability, and ...
ADHD is associated with impulsivity, hyperactivity, and trouble with focus, but kids with ADHD may also struggle with motor ...
Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...
Focus ADHD is an online psychiatric clinic based in Des Moines, Iowa, offering personalized treatment for adult professionals living with ADHD. The clinic provides expert medication management, ...
ADHD diagnosis, which largely originated in the United States, began to spread to the rest of the globe in the late 1990s, ...
Are you or your loved one struggling with the overwhelming effects of trauma, PTSD, or substance abuse? Perhaps your child is facing challenges with ADHD, autism spectrum disorders, or behavioral ...
Boys who stopped ADHD treatment at higher risk for negative consequences. Oct. 16, 2012 — -- Young boys who discontinue treatment for attention deficit hyperactivity disorder (ADHD) are featured ...
TwistedSifter on MSN
New study shows that women get an ADHD diagnosis five years later than men, even when their symptoms arise at the same age
Gendered diagnosis screening may be necessary.
Following the changes made today, more New Zealanders with ADHD will have faster access to support as a result of changes to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results